Clinical trials referenced in this document:
Documents that mention this clinical trial
Characterization of the benign lesions with increased 68Ga-FAPI-04 uptake in PET/CT
https://doi.org/10.1007/s12149-021-01673-w
68Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients
https://doi.org/10.1007/s12149-022-01742-8
Funding for this research was provided by:
National Natural Science Foundation of China (81971651, 82171982)
Natural Science Foundation of Fujian (2019J01454, 2020J05249)
Fujian Provincial Health Commission Science and Technology and Programme (2020GGA045)
Article History
Received: 23 September 2021
Accepted: 10 April 2022
First Online: 12 May 2022
Declarations
:
: The authors declare that they have no conflict of interest.
: The study was approved by the institutional review board of our hospital and written informed consent for publication of this report was obtained from the patients.